Siga Technologies INC Gain (Loss) on Extinguishment of Debt
Siga Technologies INC (SIGA) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-03-02
- Siga Technologies INC gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was $0.00.
- Siga Technologies INC gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was $0.00.
- Siga Technologies INC gain (loss) on extinguishment of debt for the quarter ending 2021-06-30 was $0.00.
- Siga Technologies INC gain (loss) on extinguishment of debt for the quarter ending 2021-03-31 was $0.00.
- Siga Technologies INC gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
- Siga Technologies INC gain (loss) on extinguishment of debt for fiscal 2021 was $0.00.
- Siga Technologies INC gain (loss) on extinguishment of debt for fiscal 2020 was -$4.98M.
- Siga Technologies INC gain (loss) on extinguishment of debt for fiscal 2019 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-02 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $0.00 derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $0.00 derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | -$4.98M 10-K · filed 2023-03-02 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | -$4.98M 10-Q · filed 2021-11-04 | -$4.98M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | -$4.98M 10-Q · filed 2021-08-05 | -$4.98M derived: sum of 3 quarters · filed 2022-03-03 | -$4.98M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | -$4.98M 10-Q · filed 2021-05-06 | -$4.98M derived: sum of 2 quarters · filed 2022-03-03 | -$4.98M derived: sum of 3 quarters · filed 2022-03-03 | -$4.98M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $0.00 derived: sum of 2 quarters · filed 2022-03-03 | $0.00 derived: sum of 3 quarters · filed 2022-03-03 | $0.00 10-K · filed 2022-03-03 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |